A new commentary in the American Journal of Psychiatry, the authors argue that clinicians should define near term treatment goals when prescribing benzodiazepines.
The commentary titled “Defining Near Term Treatment Goals for Benzodiazepine Use in Clinical Practice” appears in the September 2026 issue.
Psychiatrist Apurva Parikh of Stony Brook Medicine, Geoffrey Russell and Mark Olfson wrote the commentary. Olfson’s research on prescribing patterns has helped shape the national conversation on psychiatric medication use when treating mental health issues.
What the Commentary Argues
Benzodiazepines such as alprazolam, lorazepam and diazepam have approval for short term relief of anxiety, panic and insomnia. However, prescriptions can continue for sometimes months or years without a scheduled review.
Clinicians and patients may not revisit whether the benzodiazepine still works or what endpoint they want to reach. The commentary argues that written near term goals at the start of treatment give both sides a much clearer benchmark. That approach turns continued use into a deliberate decision rather than a default one.
This idea fits a broader shift in psychiatry toward deprescribing. The commentary also cites recent consensus guidance on prescribing and tapering these medications.
The stakes go beyond prescribing habits, because long term benzodiazepine use can lead to dependence and cognitive effects.
The Benzodiazepine Withdrawal Problem
Discontinuing after sustained use can trigger conditions such as severe anxiety and rebound symptoms that feel worse than the original condition. Safe tapering requires medical supervision at all times.
Many people need a gradual taper that lasts weeks or months. Some need a structured detox program.
This concern directly affects treatment decisions because a patient who has taken a benzodiazepine for years and wants to stop needs coordinated care. A prescriber can control the taper while a medically supervised detox setting may provide support during the early phase.
What This Means for Treatment Seekers
If you or someone you love takes a benzodiazepine every day and has done so for months or years, three practical points can help.
Ask the prescriber about the treatment goal and when the provider plans to review it. Never stop a benzodiazepine abruptly as a gradual supervised taper provides the safer approach.
Recognize that dependence remains treatable. If stopping feels out of reach, addiction treatment programs with medical detox capabilities can manage benzodiazepine tapers.
It also helps to distinguish appropriate monitored use from misuse. Many people take these medications as prescribed and still develop dependence. Tolerance and physical dependence result from pharmacological effects rather than moral failure.
Exploring Treatment Options
People who need help tapering or who have moved into misuse have several treatment options. Outpatient tapering under a prescriber works for many people. Medically supervised detox can help people who take high daily doses who have long histories of use.
Residential addiction treatment provides additional structure for people whose use overlaps with other conditions.
When you compare rehab centers ask specifically about benzodiazepine taper protocols. Rehab.com’s directory includes verified treatment centers with facilities that cover medical capabilities.
Search rehab centers by location. Compare addiction treatment programs before you decide. You can call
800-985-8516
( 
Sponsored Helpline )
to speak with a treatment advisor and discuss treatment options near you. Take the first step to recovery today.
